Yi-Teng Hung Yau-Ren Chang Hsuan-Ning Wang Wei-Chen Lee Chen-Fang Lee Chun-Bing Chen
10.3389/fimmu.2022.917782
Front Immunol
2022 Aug 18;13:917782.
stevens-johnson syndrome anti-tnf-α graft-versus-host disease immunomodulant liver transplantation target therapy
CC BY
https://pubmed.ncbi.nlm.nih.gov/36059444/
Graft vs Host Disease / diagnosis Graft vs Host Disease / drug therapy Graft vs Host Disease / etiology Liver Transplantation / adverse effects Pancytopenia Sepsis / complications Stevens-Johnson Syndrome / diagnosis Stevens-Johnson Syndrome / etiology Stevens-Johnson Syndrome / therapy
Graft vs Host Disease / diagnosis Graft vs Host Disease / drug therapy Graft vs Host Disease / etiology Liver Transplantation / adverse effects Pancytopenia Sepsis / complications Stevens-Johnson Syndrome / diagnosis Stevens-Johnson Syndrome / etiology Stevens-Johnson Syndrome / therapy Case Reports Adrenal Cortex Hormones / therapeutic use Humans Immunosuppressive Agents / adverse effects Male Middle Aged Tacrolimus Tumor Necrosis Factor Inhibitors Tumor Necrosis Factor-alpha / therapeutic use Adrenal Cortex Hormones Immunosuppressive Agents Tumor Necrosis Factor Inhibitors Tumor Necrosis Factor-alpha Tacrolimus
PMC9433559
36059444
Diagnostic and therapeutic dilemma in Stevens-Johnson syndrome-like acute graft-versus-host disease after liver transplantation: A case report
2022